Sonic Gp LLC Fennec Pharmaceuticals Inc. Transaction History
Sonic Gp LLC
- $75.8 Billion
- Q1 2024
A detailed history of Sonic Gp LLC transactions in Fennec Pharmaceuticals Inc. stock. As of the latest transaction made, Sonic Gp LLC holds 2,407,357 shares of FENC stock, worth $14.7 Million. This represents 35.34% of its overall portfolio holdings.
Number of Shares
2,407,357
Previous 2,407,357
-0.0%
Holding current value
$14.7 Million
Previous $27 Billion
0.89%
% of portfolio
35.34%
Previous 31.03%
Shares
1 transactions
Others Institutions Holding FENC
# of Institutions
69Shares Held
14.4MCall Options Held
53.2KPut Options Held
83.9K-
Southpoint Capital Advisors LP New York, NY4.08MShares$24.9 Million1.02% of portfolio
-
Dg Capital Management, LLC New York, NY1.51MShares$9.24 Million10.39% of portfolio
-
Solas Capital Management, LLC Darien, CT1.11MShares$6.78 Million8.43% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.01MShares$6.19 Million0.0% of portfolio
-
Black Rock Inc. New York, NY927KShares$5.67 Million0.0% of portfolio
About FENNEC PHARMACEUTICALS INC.
- Ticker FENC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,067,300
- Market Cap $159M
- Description
- Fennec Pharmaceuticals Inc. operates as a biopharmaceutical company. Its product candidate in the clinical stage of development is PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec...